| NCT ID | NCT06189352 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oslo Metropolitan University |
| Condition | Preterm Infant |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2024-10-14 |
| Primary Completion | 2025-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2024-10-14 with a primary completion date of 2025-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this feasibility study is to assess the feasibility to implement a feeding strategy for preterm infants. The main questions it aims to answer are: * Is it feasible to implement the PoP-intervention in a level 3a category Neonatal intensive care unit? * Is the PoP-intervention acceptable for parents of preterm infants and health care personnel working in Neonatal intensive care unit? Parents of preterm infants and health care personnel will be asked to follow a protocol of a feeding strategy based on the preterm infants development and cues throughout the NICU-stay.
Eligibility Criteria
Inclusion Criteria: * gestational age of 28 weeks * post menstrual age of 28 weeks after transition from regional hospital Exclusion Criteria: * diagnoses or malformations that makes eating difficult * triplets or more * parents not speaking/understanding Norwegian or English * parents with challenges or special needs for follow up
Contact & Investigator
Nina M Kyno, PhD
PRINCIPAL INVESTIGATOR
Oslo Metropolitan University
Frequently Asked Questions
Who can join the NCT06189352 clinical trial?
This trial is open to participants of all sexes, studying Preterm Infant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06189352 currently recruiting?
Yes, NCT06189352 is actively recruiting participants. Contact the research team at ninam@oslomet.no for enrollment information.
Where is the NCT06189352 trial being conducted?
This trial is being conducted at Drammen, Norway.
Who is sponsoring the NCT06189352 clinical trial?
NCT06189352 is sponsored by Oslo Metropolitan University. The principal investigator is Nina M Kyno, PhD at Oslo Metropolitan University. The trial plans to enroll 15 participants.